Interstitial Lung Disease Trial, Recruiting NCT06326957 Sponsor: King's College Hospital NHS Trust Condition: Interstitial Lung Disease
Back to Interstitial Lung Disease

Interstitial Lung Disease Trial, Recruiting

NCT06326957
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You experience ongoing shortness of breath, either at rest, during activity, or both
  • Your shortness of breath has lasted for more than 3 months and continues even with treatment for an underlying condition, such as cancer, COPD, interstitial lung disease, bronchiectasis, or long-term lung problems following COVID-19
  • Your breathlessness is significant enough that you get short of breath when walking quickly on flat ground or going up a gentle hill (or worse than this)
  • You have access to a computer, tablet, or smartphone with an internet connection
  • You are able to give your consent to take part in the trial

Who may not be able to join:

  • Your shortness of breath does not have a known medical cause
  • Your main diagnosis is chronic hyperventilation syndrome (a breathing condition where you breathe too fast or too deeply on an ongoing basis)
  • You are currently taking part in a rehabilitation programme, such as pulmonary or cardiac rehabilitation — though if you finished such a programme more than 4 weeks ago, you may still be eligible (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Charles C Reilly, PhD,MSc,BSc, King's College Hospital NHS Foundation Trust, King's College London

Phone: 00442032998062

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
King's College Hospital NHS Trust
Registry
ClinicalTrials.gov
Start date
4 July 2024
Est. completion
1 February 2028

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Numerical Rating Scale (NRS) Worst Breathlessness

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov